Like With The Active Substance Of The Fuelizumab

  Address - Slovakia

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 115971123

  Document Type - Tender Notices

Description - Description: The subject of the order is: a drug with the active substance fuiveizumab Fuilizumab is a surcharged humanized monoclonal antibody produced by DNA technology in host cells of myeloma mice.One 0.5 ml vial contains 50 mg fuiveizumabThe dru g is indicated to prevent serious lower respiratory disease requiring hospitalization, which is caused by respiratory syncycial virus (RSV) in children with a high risk of RSV: • Children born at the 35th week of pregnancy or earlier and at the beginning of the RSV season are younger than 6 months; • Children under 2 years in the past 6 months needed treatment of bronchopulmonary dysplasia; • Children under 2 years of age with hemodynamical

Mt Ref Id - 115971123

Deadline - Sep 23, 2025